IL109227A - Leustroducsin H pharmaceutical composition containing the same and processes for the preparation thereof - Google Patents

Leustroducsin H pharmaceutical composition containing the same and processes for the preparation thereof

Info

Publication number
IL109227A
IL109227A IL10922794A IL10922794A IL109227A IL 109227 A IL109227 A IL 109227A IL 10922794 A IL10922794 A IL 10922794A IL 10922794 A IL10922794 A IL 10922794A IL 109227 A IL109227 A IL 109227A
Authority
IL
Israel
Prior art keywords
compound
formula
acid
leustroducsin
compounds
Prior art date
Application number
IL10922794A
Other languages
English (en)
Other versions
IL109227A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL109227A0 publication Critical patent/IL109227A0/xx
Publication of IL109227A publication Critical patent/IL109227A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL10922794A 1993-04-23 1994-04-05 Leustroducsin H pharmaceutical composition containing the same and processes for the preparation thereof IL109227A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9805893 1993-04-23

Publications (2)

Publication Number Publication Date
IL109227A0 IL109227A0 (en) 1994-07-31
IL109227A true IL109227A (en) 1998-01-04

Family

ID=14209715

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10922794A IL109227A (en) 1993-04-23 1994-04-05 Leustroducsin H pharmaceutical composition containing the same and processes for the preparation thereof

Country Status (18)

Country Link
US (1) US5409912A (de)
EP (1) EP0622372B1 (de)
JP (1) JPH072886A (de)
CN (1) CN1050845C (de)
AT (1) ATE166058T1 (de)
AU (1) AU665488B2 (de)
CA (1) CA2121735A1 (de)
CZ (1) CZ286364B6 (de)
DE (1) DE69410159T2 (de)
DK (1) DK0622372T3 (de)
ES (1) ES2116528T3 (de)
FI (1) FI941850L (de)
HU (1) HU220223B (de)
IL (1) IL109227A (de)
NO (1) NO303640B1 (de)
NZ (1) NZ260364A (de)
PH (1) PH30180A (de)
RU (1) RU2098422C1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040335A (en) * 1995-10-17 2000-03-21 Suntory Limited Therapeutics for thrombocytopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2865302B2 (ja) * 1988-02-13 1999-03-08 サントリー株式会社 ２―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JPH05213758A (ja) * 1992-02-06 1993-08-24 Sankyo Co Ltd 血小板増多剤

Also Published As

Publication number Publication date
FI941850A7 (fi) 1994-10-24
DK0622372T3 (da) 1999-02-15
DE69410159T2 (de) 1999-01-28
PH30180A (en) 1997-01-21
EP0622372B1 (de) 1998-05-13
US5409912A (en) 1995-04-25
AU5932394A (en) 1994-10-27
JPH072886A (ja) 1995-01-06
CZ96494A3 (en) 1994-11-16
CN1050845C (zh) 2000-03-29
ATE166058T1 (de) 1998-05-15
HK1007857A1 (en) 1999-04-23
HUT68015A (en) 1995-05-29
NO303640B1 (no) 1998-08-10
FI941850A0 (fi) 1994-04-21
IL109227A0 (en) 1994-07-31
CN1105027A (zh) 1995-07-12
NO941478D0 (no) 1994-04-22
RU2098422C1 (ru) 1997-12-10
ES2116528T3 (es) 1998-07-16
AU665488B2 (en) 1996-01-04
HU220223B (hu) 2001-11-28
FI941850L (fi) 1994-10-24
HU9401159D0 (en) 1994-07-28
DE69410159D1 (de) 1998-06-18
NO941478L (no) 1994-10-24
NZ260364A (en) 1995-07-26
CZ286364B6 (cs) 2000-03-15
CA2121735A1 (en) 1994-10-24
EP0622372A1 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
US6214978B1 (en) Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus
US5443972A (en) Process to prepare leustroducsins
US4831053A (en) Composition for prophylaxis and therapy of hepatitis
US5409912A (en) Leustroducsin H, its preparation and its therapeutic use
JPH0359913B2 (de)
EP0317292B1 (de) Antibiotika der Mureidomycin-Gruppe, deren Herstellung und deren Verwendung
HK1007857B (en) New compound, leustroducsin h, its preparation and its therapeutic use
JP3034646B2 (ja) Ｇ−ｃｓｆおよびｇｍ−ｃｓｆ誘導剤
JPH09315996A (ja) 強心剤
JPS6337098B2 (de)
JPH05213758A (ja) 血小板増多剤
JPH07278055A (ja) 抗菌性物質ｂｅ−４０６６５類
JPH08269061A (ja) 抗腫瘍性物質エポラクタエン
WO1996026956A1 (en) Protein phosphatase inhibitor
HK1003573B (en) New antibiotics of the mureidomycin group, their preparation, and their therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees